Cat#:PA-3729F;Product Name:Mouse Anti-Cancer Antigen CA19-9 Antibody;Synonym:Cancer Antigen CA19-9; CA19.9; Ovarian tumor antigen; Pancreatic tumor antigen; Sialyl Lewis a; CA19-9; carbohydrate antigen 19-9; cancer antigen 19-9; sialylated Lewis (a) antigen;Background:CA19-9 (carbohydrate antigen 19-9, also called cancer antigen 19-9 or sialylated Lewis (a) antigen) is a blood test from the tumor marker category. It was discovered in patients with colon cancer and pancreatic cancer in 1981. According to Takada et al. (1993) (Takada et al., 1993) sialyl Lewis a antigen is mainly responsible for adhesion of human colon, pancreas and gastric cancer cells to the endothelium as well as bladder cancer. Increased levels of CA19-9 are also found in non-malignant conditions, such as Mirizzi's syndrome and diseases of the bile ducts and liver.;Description:Mouse Anti-Cancer Antigen CA19-9 Monoclonal Antibody;Host Species:Mouse;Species Reactivity:Bacteria;Isotype:IgG1;Application:ELISA, Pr;Storage:Store antibody products at 2-8°C. For long term storage, aliquot and freeze at -20°C. Avoid repeated freeze/thaw cycles;Usage:For Lab Research Use Only;
Cancer Antigen CA19-9; CA19.9; Ovarian tumor antigen; Pancreatic tumor antigen; Sialyl Lewis a; CA19-9; carbohydrate antigen 19-9; cancer antigen 19-9; sialylated Lewis (a) antigen
Gene Introduction:
CA19-9 (carbohydrate antigen 19-9, also called cancer antigen 19-9 or sialylated Lewis (a) antigen) is a blood test from the tumor marker category. It was discovered in patients with colon cancer and pancreatic cancer in 1981. According to Takada et al. (1993) (Takada et al., 1993) sialyl Lewis a antigen is mainly responsible for adhesion of human colon, pancreas and gastric cancer cells to the endothelium as well as bladder cancer. Increased levels of CA19-9 are also found in non-malignant conditions, such as Mirizzi's syndrome and diseases of the bile ducts and liver.